Letters /
September 2011
In the letter “Drug therapy decision course misleading” [BCMJ 2011;53:259-260], the author expresses concern with the content and messages he took from some of the presentations at our 22nd Annual Drug Therapy... Read More
Letters /
December 2005
Drs Miller and Humphries[1] raise important issues regarding serious adverse events (SAEs) that merit further discussion, particularly in relation to our Therapeutics Letter #48, “Do statins have a role... Read More
